{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:10:29Z","timestamp":1784196629398,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article discusses the updated 2024 European Society of Cardiology guidelines on chronic coronary syndromes and situates them within the context of Dutch clinical practice. A\u00a0working group was appointed by the Netherlands Society of Cardiology (Nederlandse Vereniging voor Cardiologie). It consisted of a\u00a0general cardiologist, interventional cardiologists, cardiovascular imaging cardiologists, and a\u00a0representative of the Dutch Heart Foundation (Nederlandse Hartstichting). This document summarizes the key recommendations and includes additional guidance tailored to clinical practice in the Netherlands, focusing on the risk-factor-weighted clinical likelihood model, the choice of non-invasive imaging modality, functional assessment of epicardial artery stenosis during invasive coronary angiography, and angina and ischemia with non-obstructive coronary arteries. It is intended for all healthcare professionals involved in the care of patients with chronic coronary syndromes and has been approved by the Netherlands Society of Cardiology and the Dutch Heart Foundation.<\/jats:p>","DOI":"10.1007\/s12471-026-02059-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:30:41Z","timestamp":1783672241000},"page":"244-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["2024 European Society of Cardiology guidelines for the management of chronic coronary syndromes"],"prefix":"10.1007","volume":"34","author":[{"given":"Alexander","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo H. B.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten A. H.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Ruigrok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik J.","family":"Grundeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2059_CR1","doi-asserted-by":"crossref","unstructured":"Knuuti J, Wijns W, Saraste A, et\u00a0al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2059_CR2","doi-asserted-by":"crossref","unstructured":"Vrints C, Andreotti F, Koskinas KC, et\u00a0al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"2059_CR3","unstructured":"FMS richtlijn Diagnostiek bij angina pectoris 2021. [Accessed 26\u00a0January 2026]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/diagnostiek_bij_angina_pectoris_ap\/startpagina_-_diagnostiek_bij_angina_pectoris_ap.html."},{"key":"2059_CR4","unstructured":"NHG\/NVVC Landelijke transmurale afspraak stabiele angina pectoris 2020. [Accessed 26\u00a0January 2026]. Available from: https:\/\/nvvc.nl\/thema-kwaliteit\/richtlijnen\/default.aspx."},{"key":"2059_CR5","unstructured":"NVVC Leidraad Pijn op de borst zonder obstructief coronairlijden 2020. [Accessed 26\u00a0January 2026]. Available from: https:\/\/nvvc.nl\/thema-kwaliteit\/richtlijnen\/default.aspx."},{"key":"2059_CR6","doi-asserted-by":"crossref","unstructured":"Winther S, Schmidt SE, Mayrhofer T, et\u00a0al. Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease. J\u00a0Am Coll Cardiol. 2020;76(21):2421\u201332.","DOI":"10.1016\/j.jacc.2020.09.585"},{"key":"2059_CR7","doi-asserted-by":"crossref","unstructured":"Winther S, Nissen L, Westra J, et\u00a0al. Pre-test probability prediction in patients with a\u00a0low to intermediate probability of coronary artery disease: a\u00a0prospective study with a\u00a0fractional flow reserve endpoint. Eur Heart J Cardiovasc Imaging. 2019;20(11):1208\u201318.","DOI":"10.1093\/ehjci\/jez058"},{"key":"2059_CR8","doi-asserted-by":"crossref","unstructured":"Mortensen MB, Gaur S, Frimmer A, et\u00a0al. Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients. JAMA Cardiol. 2022;7(1):36\u201344.","DOI":"10.1001\/jamacardio.2021.4406"},{"key":"2059_CR9","doi-asserted-by":"crossref","unstructured":"Williams MC, Wereski R, Tuck C, et\u00a0al. Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland. Lancet. 2025;405(10475):329\u201337.","DOI":"10.1016\/S0140-6736(24)02679-5"},{"key":"2059_CR10","doi-asserted-by":"crossref","unstructured":"Sakai K, Shin D, Singh M, et\u00a0al. Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease. J\u00a0Am Coll Cardiol. 2025;85(4):339\u201348.","DOI":"10.1016\/j.jacc.2024.10.069"},{"key":"2059_CR11","doi-asserted-by":"crossref","unstructured":"Sharma SP, Lemmens MDK, Smulders MW, Budde RPJ, Hirsch A, Mihl C. Photon-counting detector computed tomography in cardiac imaging. Neth Heart J. 2024;32(11):405\u201316.","DOI":"10.1007\/s12471-024-01904-5"},{"key":"2059_CR12","doi-asserted-by":"crossref","unstructured":"Sharma SP, Hirsch A, Hunink MGM, et\u00a0al. Addition of FFRct in the diagnostic pathway of patients with stable chest pain to reduce unnecessary invasive coronary angiography (FUSION) : Rationale and design for the multicentre, randomised, controlled FUSION trial. Neth Heart J. 2023;31(2):52\u201360.","DOI":"10.1007\/s12471-022-01711-w"},{"key":"2059_CR13","doi-asserted-by":"crossref","unstructured":"Danad I, Raijmakers PG, Driessen RS, et\u00a0al. Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve. JAMA Cardiol. 2017;2(10):1100\u20137.","DOI":"10.1001\/jamacardio.2017.2471"},{"key":"2059_CR14","doi-asserted-by":"crossref","unstructured":"Jukema RA, Dahdal J, Kooijman EM, et\u00a0al. Diagnostic accuracy of non-invasive cardiac imaging modalities in patients with a\u00a0history of coronary artery disease: a\u00a0meta-analysis. Heart. 2024;111(1):4\u201310.","DOI":"10.1136\/heartjnl-2024-324248"},{"key":"2059_CR15","doi-asserted-by":"crossref","unstructured":"Pontone G, Guaricci AI, Palmer SC, et\u00a0al. Diagnostic performance of non-invasive imaging for stable coronary artery disease: A\u00a0meta-analysis. Int J Cardiol. 2020;300:276\u201381.","DOI":"10.1016\/j.ijcard.2019.10.046"},{"key":"2059_CR16","unstructured":"Verbetersignalement Pijn op de Borst 2017. [Accessed 26\u00a0January 2026]. Available from: https:\/\/www.zorginstituutnederland.nl\/documenten\/2018\/01\/31\/zinnige-zorg-verbetersignalement-pijn-op-de-borst."},{"key":"2059_CR17","doi-asserted-by":"crossref","unstructured":"Rizvi A, Han D, Danad I, et\u00a0al. Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A\u00a0Meta-Analysis. JACC Cardiovasc Imaging. 2018;11(4):589\u201399.","DOI":"10.1016\/j.jcmg.2017.05.020"},{"key":"2059_CR18","doi-asserted-by":"crossref","unstructured":"Rasmussen LD, Winther S, Eftekhari A, et\u00a0al. Second-Line Myocardial Perfusion Imaging to Detect Obstructive Stenosis: Head-to-Head Comparison of CMR and PET. JACC Cardiovasc Imaging. 2023;16(5):642\u201355.","DOI":"10.1016\/j.jcmg.2022.11.015"},{"key":"2059_CR19","doi-asserted-by":"crossref","unstructured":"Maaniitty T, Stenstrom I, Bax JJ, et\u00a0al. Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease. JACC Cardiovasc Imaging. 2017;10(11):1361\u201370.","DOI":"10.1016\/j.jcmg.2016.10.025"},{"key":"2059_CR20","doi-asserted-by":"crossref","unstructured":"Pezel T, Hovasse T, Lefevre T, et\u00a0al. Prognostic Value of Stress CMR in Symptomatic Patients With Coronary Stenosis on CCTA. JACC Cardiovasc Imaging. 2022;15(8):1408\u201322.","DOI":"10.1016\/j.jcmg.2022.03.008"},{"key":"2059_CR21","doi-asserted-by":"crossref","unstructured":"Winther S, Andersen IT, Gormsen LC, et\u00a0al. Prognostic value of myocardial perfusion imaging after first-line coronary computed tomography angiography: A\u00a0multi-center cohort study. J\u00a0Cardiovasc Comput Tomogr. 2022;16(1):34\u201340.","DOI":"10.1016\/j.jcct.2021.08.001"},{"key":"2059_CR22","doi-asserted-by":"crossref","unstructured":"Verpalen VA, Coerkamp CF, Hinderks MJ, et\u00a0al. Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial. Neth Heart J. 2024;32(11):387\u201396.","DOI":"10.1007\/s12471-024-01906-3"},{"key":"2059_CR23","doi-asserted-by":"crossref","unstructured":"Davies JE, Sen S, Dehbi HM, et\u00a0al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376(19):1824\u201334.","DOI":"10.1056\/NEJMoa1700445"},{"key":"2059_CR24","doi-asserted-by":"crossref","unstructured":"Xu B, Tu S, Song L, et\u00a0al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a\u00a0multicentre, randomised, sham-controlled trial. Lancet. 2021;398(10317):2149\u201359.","DOI":"10.1016\/S0140-6736(21)02248-0"},{"key":"2059_CR25","doi-asserted-by":"crossref","unstructured":"Andersen BK, Sejr-Hansen M, Maillard L, et\u00a0al. Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a\u00a0multicentre, randomised, non-inferiority trial. Lancet. 2024;404(10465):1835\u201346.","DOI":"10.1016\/S0140-6736(24)02175-5"},{"key":"2059_CR26","doi-asserted-by":"crossref","unstructured":"Hara H, Serruys PW, O\u2019Leary N, et\u00a0al. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design. Am Heart J. 2022;246:32\u201343.","DOI":"10.1016\/j.ahj.2021.12.018"},{"key":"2059_CR27","unstructured":"FMS richtlijn Hartrevalidatie 2024. [Accessed 26\u00a0April 2026]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/hartrevalidatie\/hartrevalidatie_-_startpagina.html."},{"key":"2059_CR28","unstructured":"Standpunt Hartrevalidatie bij stabiele angina pectoris en boezemfibrilleren van Zorginstituut Nederland. [Accessed 26\u00a0April 2026]. Available from: https:\/\/www.zorginstituutnederland.nl\/documenten\/2026\/03\/26\/standpunt-hartrevalidatie."},{"key":"2059_CR29","unstructured":"FMS richtlijn Cardiovasculair risicomanagement 2024. [Accessed 26\u00a0January 2026]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/cardiovasculair_risicomanagement_cvrm\/samenvatting_richtlijn_cardiovasculair_risicomanagement.html."},{"key":"2059_CR30","doi-asserted-by":"crossref","unstructured":"Chiarito M, Sanz-Sanchez J, Cannata F, et\u00a0al. Monotherapy with a\u00a0P2Y(12) inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a\u00a0systematic review and meta-analysis. Lancet. 2020;395(10235):1487\u201395.","DOI":"10.1016\/S0140-6736(20)30315-9"},{"key":"2059_CR31","doi-asserted-by":"crossref","unstructured":"Perera D, Clayton T, O\u2019Kane PD, et\u00a0al. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N Engl J Med. 2022;387(15):1351\u201360.","DOI":"10.1056\/NEJMoa2206606"},{"key":"2059_CR32","doi-asserted-by":"crossref","unstructured":"Konst RE, Damman P, Pellegrini D, et\u00a0al. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm. Int J Cardiol. 2021;333:14\u201320.","DOI":"10.1016\/j.ijcard.2021.02.079"},{"key":"2059_CR33","doi-asserted-by":"crossref","unstructured":"Ford TJ, Stanley B, Good R, et\u00a0al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J\u00a0Am Coll Cardiol. 2018;72(23 Pt A):2841-55.","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"2059_CR34","doi-asserted-by":"crossref","unstructured":"Boerhout CKM, Namba HF, Liu T, et\u00a0al. Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial. Eur Heart J. 2025;46(42):4396\u2013406.","DOI":"10.1093\/eurheartj\/ehaf580"},{"key":"2059_CR35","doi-asserted-by":"crossref","unstructured":"Crooijmans C, Jansen TPJ, Meeder JG, et\u00a0al. Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function Testing. JAMA Cardiol. 2025;10(4):384\u201390.","DOI":"10.1001\/jamacardio.2024.5670"},{"key":"2059_CR36","unstructured":"Keuzehulp coronaire functietest. [Accessed 26\u00a0January 2026]. Available from: https:\/\/www.hartstichting.nl\/hart-en-vaatziekten\/vrouwen-en-hart-en-vaatziekten\/problemen-de-kleine-vaatjes-van-het-hart."}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-026-02059-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:01:52Z","timestamp":1784196112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-026-02059-1"}},"subtitle":["Statement of endorsement by the NVVC"],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":36,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1007\/s12471-026-02059-1","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Hirsch received a\u00a0research grant and consultancy fees from GE Healthcare and speaker fees from GE Healthcare, Bayer, Bristol Myers Squibb, Siemens Healthineers, and Heartflow. He is also a\u00a0member of the medical advisory board of Medis Medical Imaging Systems and was MRI corelab supervisor of Cardialysis BV until 2022. Erasmus MC received institutional support from Siemens Healthineers, Heartflow, and Bracco. P.\u00a0Damman received research grants from Philips, Abbott, AstraZeneca, Pie Medical Imaging. M.\u00a0Guglielmo received a\u00a0speaker\u2019s fee from Circle Cardiovascular Imaging. M.A.H.\u00a0van Leeuwen received honoraria for speaking\/consulting services from Terumo, Daiichi-Sankyo, and Abbott and research grants from AstraZeneca, Top Sector Life Sciences & Health, Terumo, Top Medical B.V, and Abbott. M.J.\u00a0Grundeken received research grant from Abbott Vascular and Speaker fees paid to his institution from Boston Scientific, Medtronic and Philips\/Volcano. L.H.B.\u00a0Baur and S.\u00a0Ruigrok declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}